The Robot Workforce
In 2026 humanoid robots stopped being demos and started clocking shifts. Inside Figure’s year at BMW, the $16,000 price war, and what it means for human work.
The Motion Problem
AlphaFold solved the static shape of proteins. The 2026 frontier is motion — AI that predicts how proteins flex, breathe, and bind. Here’s the leap.
The Drug Engine
A 1,016-GPU supercomputer and a $2.5B AI drug deal show how, in 2026, artificial intelligence became the infrastructure of drug discovery itself.
The Model That Went Dark
On June 12, 2026 a single export-control order forced Anthropic to take its most powerful AI models offline worldwide. What it reveals about who controls AI.
The Hard Horizon
AI agents can work for hours and keep getting longer — but brutal new June 2026 marathon benchmarks show full autonomy is still far off. Here’s the real state of play.
The Fair-Use Frontier
A $1.5B Anthropic settlement, 70+ suits, and the first appellate fair-use argument: inside the court fight over whether AI could train on copyrighted work.
The Crown Changes Hands
Anthropic passed OpenAI, Claude Opus 4.8 topped the leaderboard, Gemini Deep Think landed. Inside the most compressed frontier AI race yet — and where it heads.
The Defection
AlphaFold’s Nobel laureate left DeepMind for Anthropic. What John Jumper’s move reveals about the future of AI-driven biology and where it now gets built.
The Resistance
With 39 million antibiotic-resistance deaths projected by 2050, generative AI is designing brand-new antibiotics from billions of molecules — and they’re killing superbugs.
The Inner Voice
AI brain implants can now turn neural signals — even silent, imagined speech — into spoken words in under a second, restoring voice and raising mental-privacy stakes.
Buy me a coffee